Run-of-the-mill narrative surrounding lung cancer no longer holds: up to 25% of cases globally now occur in people who have never smoked, especially among women, youth, and individuals of Asian descent. Experts are launching an urgent mission to uncover why—and early genomic evidence is beginning to shed light on surprising causes.
Annie Chen, 48, from New Jersey, discovered her Stage 4 lung cancer after two years of breathlessness. “My whole world crashed,” she recalls. Chen had never smoked, yet she inherited a family history of lung cancer—her father died of it at 71. This story is no anomaly. Thanks to reduced smoking rates, lung cancers in nonsmokers, particularly adenocarcinoma (the most common form in nonsmokers), are increasingly prevalent.
Sherlock-Lung: Genomic Sleuthing at Work
In an unprecedented global effort, the “Sherlock‑Lung” study examined whole genomes from 871 nonsmokers diagnosed with lung cancer across four continents.
Researchers discovered a clear correlation: living in regions with high PM2.5 air pollution—such as Hong Kong, Taiwan, Milan, New York, and Uzbekistan—maps to a surge in mutations commonly associated with smoking, including TP53 and SBS4 signatures.
Telomere shortening, a marker of accelerated cellular aging, correlated with pollution exposure.
SBS40a, a newly identified mutation cluster of unknown origin, was widespread among nonsmokers, often alongside EGFR mutations.
A regional genetic signature, SBS22a, linked to aristolochic acid in herbal medicines, was found almost exclusively in Taiwanese patients—highlighting region-specific environmental factors.
Unlike air pollution, exposure to secondhand tobacco smoke only modestly increased mutation rates and didn’t generate the key, cancer-driving genetic signatures.
This suggests that particulate pollution from vehicles and industry is more mutagenic than passive smoking and a genuine lung cancer risk for nonsmokers.
Lung cancer remains the deadliest cancer, with 2.5 million new diagnoses yearly.
In regions like East Asia, more than 200,000 adenocarcinoma cases in 2022 were directly attributed to air pollution.
Even in the UK, over 1,100 annual cases are pollution-linked
Women, historically at lower smoking rates, are now experiencing rising lung cancer incidence—effectively narrowing the gender gap.
Understanding these genomics helps tackle lung cancer in nonsmokers more effectively—through better prevention, earlier detection, and potentially novel treatment paths rooted in their unique biology.
Other contributors include:
Genetic predispositions and family history, evidenced by high-risk clusters among nonsmoking relatives of patients like Chen and Sandra Liu.
Previous lung conditions such as COPD, bronchitis, and GERD—emerging as potential markers for future lung cancer risk in nonsmokers.
Exposure to radon, asbestos, silica, heavy metals, and indoor pollution remain under investigation.
Lung cancer in nonsmokers is rising and complex, shaped by factors beyond cigarettes. Genomic studies highlight air pollution and regional exposures as major culprits. Better awareness, targeted screening protocols, and environmental interventions are urgently needed to combat this stealthy epidemic.
READ MORE
Pandemic Accelerated Brain Aging by ~5.5 Months, Even Without COVID Infection
Scientists Grow Vascularized Lung Organoids from Stem Cells
CDC Grant Cuts Could Reverse U.S. Overdose Death Decline
